Insulin prices capped for some, cost still high for millions
Season 2024
Episode 16
About the Episode
Diabetics will now see a break in their out-of-pocket costs for insulin. Sanofi, one of the leading manufacturers of the hormone, joined two other major pharmaceutical companies in capping their insulin copays at $35. This comes after years of pressure by President Biden, lawmakers and activists for companies to lower their list prices. White House Correspondent Laura Barrón-López reports.
Aired:
| Expires: | Runtime: 8m 25s
Recent Episodes
Extras
-
News Wrap: Israel targets Lebanon with more deadly strikes
News Wrap: Israel targets eastern and southern Lebanon with more deadly airstrikes3:13 -
Future of U.S.-China relations after final Biden-Xi meeting
The future of U.S.-China relations after Biden’s final meeting with Xi7:02 -
Climate change’s role in the Northeast’s wildfire outbreak
The role of climate change in an unusual outbreak of wildfires in the Northeast5:21 -
Report highlights killings of Indigenous environmentalists
Report highlights disproportionate killings of Indigenous environmental activists8:05 -
Brooks and Capehart on the 'chaos' of Trump's Cabinet picks
Brooks and Capehart on the 'chaos' surrounding Trump's Cabinet picks10:53 -
Speaker Johnson says Gaetz report should not be released
House speaker says potentially damning ethics report on Matt Gaetz should not be released5:28 -
How 'donations' are inundating Ghana with toxic waste
How 'donations' from the West are inundating Ghana with toxic waste9:45 -
News Wrap: Biden in Peru for APEC Summit
News Wrap: Biden in Peru for APEC Summit, one of his final appearances on world stage5:25 -
Why experts are concerned about RFK Jr.'s HHS nomination
Why health experts are concerned about RFK Jr.'s HHS nomination7:27 -
What the polling got right and wrong in the election
What the polling got right and wrong in the presidential election5:45
